Pregnancy not linked to severity of Covid 19 Infection finds study

Written By :  Dr. Kamal Kant Kohli
Published On 2020-05-12 16:32 GMT   |   Update On 2023-05-23 10:04 GMT

Researchers have found that pregnant women are no more likely to become ill with severe COVID-19 than non-pregnant woman. However, the majority of women who did become severely ill were in their third trimester of pregnancy, emphasising the importance of social distancing for this group.The study looked at 427 pregnant women admitted to hospitals in the UK between 1 March and 14 April 2020...

Login or Register to read the full article

Researchers have found that pregnant women are no more likely to become ill with severe COVID-19 than non-pregnant woman. However, the majority of women who did become severely ill were in their third trimester of pregnancy, emphasising the importance of social distancing for this group.

The study looked at 427 pregnant women admitted to hospitals in the UK between 1 March and 14 April 2020 with confirmed COVID-19 (4.9 women out of every 1000 pregnant women, suggesting pregnant women are not at a higher risk of experiencing severe illness). Information for the study was collected from all 194 hospitals in the UK with a consultant-led maternity unit.

Pregnant women from black and ethnic minority backgrounds were more likely to be admitted to hospital for COVID-19. This inequality persisted even when women from London, the West Midlands and the North West were excluded from the analysis, meaning the difference cannot be explained by higher rates of COVID-19 infection in those areas.

The analysis also showed that older pregnant women, those who were overweight or obese, and pregnant women who had pre-existing medical problems, such as high blood pressure and diabetes, were more likely to be admitted to hospital with the infection. Women who were admitted to hospital with COVID-19 in pregnancy were less likely to smoke than a group of comparison pregnant women.

Other important findings from the study include:

One in five babies born to mothers hospitalised with COVID-19 were born pre-mature and were admitted to a neonatal unit

One in twenty babies born had a positive test for COVID-19, but only half of them immediately after birth

Sixty percent of the women admitted to hospital have now given birth, while the remaining forty percent have ongoing pregnancies. Most women have now been discharged home. Around one in 10 women required intensive care, and sadly five women have died.

Outcomes for babies born to mothers with COVID-19 were mostly good. Although almost one in five were born prematurely and were admitted to a neonatal unit, fewer than twenty babies were born very premature (when their mothers were less than 32 weeks pregnant). One in twenty babies born had a positive test for COVID-19, but only half of these babies had positive test immediately after birth, suggesting that transmission of infection from mother to baby is low.

Professor Marian Knight, Professor of Maternal and Child Population Health at the Nuffield Department of Population Health, University of Oxford and lead investigator for the study, said, 'A very small number of pregnant women do become severely ill with COVID-19 and sadly some women have died. Our thoughts must remain with their families. It is concerning that more pregnant women from black and minority ethnic groups are admitted with COVID-19 in pregnancy and this needs urgent investigation.

'Most pregnant women who were admitted to hospital were more than six months pregnant, which emphasises the importance of continued social distancing measures in the later stages of pregnancy. Following the current guidance about careful social distancing will help prevent infection.'

Edward Morris, President of the Royal College of Obstetricians and Gynaecologists and an author on the study, said, 'Admission with infection in pregnancy is also associated with older maternal age, overweight and obesity, and the presence of pre-existing medical conditions. Awareness of these factors is important for both women and their doctors and midwives to help ensure women receive appropriate advice about prevention and complications of COVID-19 are recognised early. Detailed advice and guidance for women is available on the RCOG website.'

Gill Walton, Chief Executive of the Royal College of Midwives, said, 'During this current crisis, pregnancies have continued, babies have been born, and, throughout it all, midwives have been at their side, supporting and caring for them. It's absolutely vital that women continue to attend antenatal appointments to ensure that they and their babies are well. Staying in touch with their maternity services team will help put any concerns at ease and enable them to act quickly when necessary.'

Information for the study was collected using a research system called the UK Obstetric Surveillance System (UKOSS). The study was funded by the National Institute for Health Research in 2012 in preparation for the possibility of a pandemic, to ensure we could collect accurate information to advise pregnant women, their midwives and doctors. It was activated in March and the information has been being used to guide the ongoing response. This study is one of a number of COVID-19 studies that have been given urgent public health research status by the Chief Medical Officer/ Deputy Chief Medical Officer for England.

For further reference log on to:

Characteristics and outcomes of pregnant women hospitalised with confirmed SARS-CoV-2 infection in the UK: a national cohort study using the UK Obstetric Surveillance System (UKOSS). (preprint): www.npeu.ox.ac.uk/downloads/fi … annual-reports/UKOSS COVID-19 Paper pre-print draft 11-05-20.pdf

Tags:    
Article Source : University of Oxford

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News